CB₁ and CB₂ Receptor Pharmacology

Area of Science:

• Neuroscience
• Pharmacology
• Molecular Biology

Background:

• Cannabinoid receptors (CB1R, CB2R) are G protein-coupled receptors (GPCRs) identified over two decades ago.
• These receptors mediate the effects of Δ9-tetrahydrocannabinol (Δ9-THC) and endogenous cannabinoids like anandamide and 2-arachidonoyl glycerol.
• CB1R and CB2R exhibit both similarities and differences in their pharmacology, recognizing various agonists and antagonists.

Purpose of the Study:

• To comprehensively discuss the pharmacological characterization, distribution, phylogeny, and signaling pathways of CB1R and CB2R.
• To explore the impact of natural polymorphisms and alternative splice variants on receptor diversity.
• To examine the effects of extended agonist exposure on receptor signaling and expression patterns.

Main Methods:

• Pharmacological characterization of CB1R and CB2R.
• Analysis of receptor distribution and phylogeny.
• Investigation of signaling pathways and downstream effects.
• Assessment of extended agonist exposure effects on receptor expression and signaling.

Main Results:

• CB1R and CB2R recognize multiple classes of agonist and antagonist compounds.
• Receptors produce a diverse array of distinct downstream effects.
• Natural polymorphisms and alternative splice variants contribute to pharmacological diversity.

Conclusions:

• Understanding the distinct differences between CB1R and CB2R can lead to targeted therapies.
• Further research into receptor conformations and pharmacological responses is warranted.
• Extended agonist exposure significantly impacts receptor signaling and expression patterns.